SEC Tracker
Get the app

NextCure NXTC

NextCure announces merger with Avere

Merger registration (amended)

Form
S-4/A
Filed
Importance
Routine
  1. Merger with Avere Therapeutics, Inc.
  2. First Merger Sub to merge with Avere, with Avere continuing as subsidiary.
  3. Second Merger Sub to merge with Avere, becoming surviving entity.
  4. Combined company to rename NextCure to Avere Therapeutics, Inc.

Written from the S-4/A on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when NextCure files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Cellectar Biosciences CLRB public float $13M, Jun 30, 2025
  2. Synergy CHC SNYR public float $13M, Jun 30, 2025
  3. Cypherpunk Technologies CYPH public float $12M, Jun 30, 2025
  4. Earth Science Tech ETST public float $14M, Mar 31, 2026
  5. Cocrystal Pharma COCP public float $12M, Jun 30, 2025